John Ransom
Stock Analyst at Raymond James
(4.61)
# 235
Out of 5,006 analysts
212
Total ratings
66.49%
Success rate
16.14%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Outperform | $26 → $30 | $26.46 | +13.38% | 10 | Oct 3, 2025 | |
| RDNT RadNet | Reiterates: Strong Buy | $66 → $75 | $78.29 | -4.20% | 12 | Aug 13, 2025 | |
| AVAH Aveanna Healthcare Holdings | Upgrades: Outperform | $9 | $8.51 | +5.76% | 8 | Aug 11, 2025 | |
| SCI Service Corporation International | Reiterates: Outperform | $85 → $90 | $83.61 | +7.64% | 13 | Aug 4, 2025 | |
| THC Tenet Healthcare | Reiterates: Outperform | $185 → $200 | $199.76 | +0.12% | 18 | Jul 23, 2025 | |
| CI The Cigna Group | Maintains: Strong Buy | $360 → $385 | $302.99 | +27.07% | 18 | May 5, 2025 | |
| UNH UnitedHealth Group | Reiterates: Strong Buy | $635 → $540 | $358.77 | +50.51% | 13 | Apr 21, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $433.55 | - | 21 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $3.09 | - | 8 | Nov 22, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.58 | +118.34% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Strong Buy | $85 → $95 | $123.62 | -23.15% | 15 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $295.20 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $22.31 | -10.35% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $23.48 | +27.77% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $17.11 | -29.87% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $76.84 | +10.62% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $112.70 | -6.83% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $8.18 | +22.25% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.96 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $27.86 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $42.06 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $27.34 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $128.14 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $20.39 | - | 2 | Aug 9, 2017 |
Acadia Healthcare Company
Oct 3, 2025
Maintains: Outperform
Price Target: $26 → $30
Current: $26.46
Upside: +13.38%
RadNet
Aug 13, 2025
Reiterates: Strong Buy
Price Target: $66 → $75
Current: $78.29
Upside: -4.20%
Aveanna Healthcare Holdings
Aug 11, 2025
Upgrades: Outperform
Price Target: $9
Current: $8.51
Upside: +5.76%
Service Corporation International
Aug 4, 2025
Reiterates: Outperform
Price Target: $85 → $90
Current: $83.61
Upside: +7.64%
Tenet Healthcare
Jul 23, 2025
Reiterates: Outperform
Price Target: $185 → $200
Current: $199.76
Upside: +0.12%
The Cigna Group
May 5, 2025
Maintains: Strong Buy
Price Target: $360 → $385
Current: $302.99
Upside: +27.07%
UnitedHealth Group
Apr 21, 2025
Reiterates: Strong Buy
Price Target: $635 → $540
Current: $358.77
Upside: +50.51%
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $433.55
Upside: -
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $3.09
Upside: -
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.58
Upside: +118.34%
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $123.62
Upside: -23.15%
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $295.20
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $22.31
Upside: -10.35%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $23.48
Upside: +27.77%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $17.11
Upside: -29.87%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $76.84
Upside: +10.62%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $112.70
Upside: -6.83%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $8.18
Upside: +22.25%
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $2.96
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $27.86
Upside: -
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $42.06
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $27.34
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $128.14
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $20.39
Upside: -